Laurus Labs receives approval from USFDA for Tenofovir Disoproxil Fumarate Tablets

01 Dec 2017 Evaluate

Laurus Labs has received its maiden tentative approval from United States Food and Drug Administration (USFDA) for Tenofovir Disoproxil Fumarate Tablets 300mg. Tenofovir Disoproxil Fumarate Tablets 300mg is therapeutically equivalent to VIREAD Tablets 300mg of Gilead Science (GILEAD). Tenofovir Disoproxil Fumarate Tablets 300mg is used for treatment of HIV-1 infection in adults and paediatric patients 2 years of age and older.

Laurus Labs is a leading research and development driven pharmaceutical company in India. The company has grown consistently to become one of the leading manufacturers of APIs for anti-retroviral (ARV) and Hepatitis C. It also manufactures APIs in oncology and other therapeutic areas.


Laurus Labs Share Price

1012.65 -5.55 (-0.55%)
04-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1818.60
Dr. Reddys Lab 1277.00
Cipla 1521.20
Zydus Lifesciences 935.20
Lupin 2091.95
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×